Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

162 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Zoledronic acid slows down rat primary chondrosarcoma development, recurrent tumor progression after intralesional curretage and increases overall survival.
Gouin F, Ory B, Rédini F, Heymann D. Gouin F, et al. Among authors: redini f. Int J Cancer. 2006 Sep 1;119(5):980-4. doi: 10.1002/ijc.21951. Int J Cancer. 2006. PMID: 16570273
Quaternary ammonium-melphalan conjugate for anticancer therapy of chondrosarcoma: in vitro and in vivo preclinical studies.
Peyrode C, Weber V, David E, Vidal A, Auzeloux P, Communal Y, Dauplat MM, Besse S, Gouin F, Heymann D, Chezal JM, Rédini F, Miot-Noirault E. Peyrode C, et al. Among authors: redini f. Invest New Drugs. 2012 Aug;30(4):1782-90. doi: 10.1007/s10637-011-9663-z. Epub 2011 Apr 16. Invest New Drugs. 2012. PMID: 21499733
Sonic Hedgehog Signature in Pediatric Primary Bone Tumors: Effects of the GLI Antagonist GANT61 on Ewing's Sarcoma Tumor Growth.
Mullard M, Cadé M, Morice S, Dupuy M, Danieau G, Amiaud J, Renault S, Lézot F, Brion R, Thepault RA, Ory B, Lamoureux F, Corre I, Brounais-LeRoyer B, Rédini F, Verrecchia F. Mullard M, et al. Among authors: redini f. Cancers (Basel). 2020 Nov 19;12(11):3438. doi: 10.3390/cancers12113438. Cancers (Basel). 2020. PMID: 33228057 Free PMC article.
Osteosarcoma of the jaws: An overview of the pathophysiological mechanisms.
Bertin H, Gomez-Brouchet A, Rédini F. Bertin H, et al. Among authors: redini f. Crit Rev Oncol Hematol. 2020 Dec;156:103126. doi: 10.1016/j.critrevonc.2020.103126. Epub 2020 Oct 10. Crit Rev Oncol Hematol. 2020. PMID: 33113487 Free article. Review.
Antagonistic Functions of Connexin 43 during the Development of Primary or Secondary Bone Tumors.
Talbot J, Dupuy M, Morice S, Rédini F, Verrecchia F. Talbot J, et al. Among authors: redini f. Biomolecules. 2020 Aug 26;10(9):1240. doi: 10.3390/biom10091240. Biomolecules. 2020. PMID: 32859065 Free PMC article. Review.
The Osteosarcoma Microenvironment: A Complex But Targetable Ecosystem.
Corre I, Verrecchia F, Crenn V, Redini F, Trichet V. Corre I, et al. Among authors: redini f. Cells. 2020 Apr 15;9(4):976. doi: 10.3390/cells9040976. Cells. 2020. PMID: 32326444 Free PMC article. Review.
Hippo/YAP Signaling Pathway: A Promising Therapeutic Target in Bone Paediatric Cancers?
Morice S, Danieau G, Rédini F, Brounais-Le-Royer B, Verrecchia F. Morice S, et al. Among authors: redini f. Cancers (Basel). 2020 Mar 10;12(3):645. doi: 10.3390/cancers12030645. Cancers (Basel). 2020. PMID: 32164350 Free PMC article. Review.
SHH Signaling Pathway Drives Pediatric Bone Sarcoma Progression.
Lézot F, Corre I, Morice S, Rédini F, Verrecchia F. Lézot F, et al. Among authors: redini f. Cells. 2020 Feb 26;9(3):536. doi: 10.3390/cells9030536. Cells. 2020. PMID: 32110934 Free PMC article. Review.
Epinephrine Infiltration of Adipose Tissue Impacts MCF7 Breast Cancer Cells and Total Lipid Content.
Avril P, Vidal L, Barille-Nion S, Le Nail LR, Redini F, Layrolle P, Pinault M, Chevalier S, Perrot P, Trichet V. Avril P, et al. Among authors: redini f. Int J Mol Sci. 2019 Nov 11;20(22):5626. doi: 10.3390/ijms20225626. Int J Mol Sci. 2019. PMID: 31717935 Free PMC article.
Integrated molecular characterization of chondrosarcoma reveals critical determinants of disease progression.
Nicolle R, Ayadi M, Gomez-Brouchet A, Armenoult L, Banneau G, Elarouci N, Tallegas M, Decouvelaere AV, Aubert S, Rédini F, Marie B, Labit-Bouvier C, Reina N, Karanian M, le Nail LR, Anract P, Gouin F, Larousserie F, de Reyniès A, de Pinieux G. Nicolle R, et al. Among authors: redini f. Nat Commun. 2019 Oct 11;10(1):4622. doi: 10.1038/s41467-019-12525-7. Nat Commun. 2019. PMID: 31604924 Free PMC article.
162 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback